Pierre Legault Bicycle Therapeutics PLC (BCYC) insider trading activity

Pierre Legault is Director of BICYCLE THERAPEUTICS plc. Currently has a direct ownership of 33,500 shares of BCYC, which is worth approximately $777,535. The most recent transaction as insider was on Jan 02, 2024, when has been sold 12,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.5K

0% 3M change

55.81% 12M change

Total Value Held $777,535

Pierre Legault Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2024	BUY Grant, award, or other acquisition	-	12,000 Added 26.37%	33,500 Ordinary Shares
Jan 03 2023	BUY Grant, award, or other acquisition	-	11,500 Added 34.85%	21,500 Ordinary Shares
Jan 03 2022	BUY Grant, award, or other acquisition	-	10,000 Added 50.0%	10,000 Ordinary Shares
Dec 22 2021	SELL Open market or private sale	$5,676,858 $58.01 p/Share	97,860 Reduced 100.0%	0 Ordinary Shares
Dec 22 2021	BUY Exercise of conversion of derivative security	$829,853 $8.48 p/Share	97,860 Added 50.0%	97,860 Ordinary Shares
Dec 21 2021	SELL Open market or private sale	$2,543,508 $57.11 p/Share	44,537 Reduced 100.0%	0 Ordinary Shares
Dec 21 2021	BUY Exercise of conversion of derivative security	$375,892 $8.44 p/Share	44,537 Added 50.0%	44,537 Ordinary Shares
Dec 20 2021	SELL Open market or private sale	$433,523 $57.02 p/Share	7,603 Reduced 100.0%	0 Ordinary Shares
Dec 20 2021	BUY Exercise of conversion of derivative security	$63,941 $8.41 p/Share	7,603 Added 50.0%	7,603 Ordinary Shares
Apr 08 2021	SELL Open market or private sale	$790,842 $31.84 p/Share	24,838 Reduced 100.0%	0 Ordinary Shares
Apr 08 2021	BUY Exercise of conversion of derivative security	$217,084 $8.74 p/Share	24,838 Added 50.0%	24,838 Ordinary Shares
Apr 05 2021	SELL Open market or private sale	$5,033 $31.07 p/Share	162 Reduced 100.0%	0 Ordinary Shares
Apr 05 2021	BUY Exercise of conversion of derivative security	$1,430 $8.83 p/Share	162 Added 50.0%	162 Ordinary Shares
Mar 31 2021	SELL Open market or private sale	$300,000 $30.0 p/Share	10,000 Reduced 100.0%	0 Ordinary Shares
Mar 31 2021	BUY Exercise of conversion of derivative security	$87,800 $8.78 p/Share	10,000 Added 50.0%	10,000 Ordinary Shares
Mar 17 2021	SELL Open market or private sale	$225,736 $29.0 p/Share	7,784 Reduced 100.0%	0 Ordinary Shares
Mar 17 2021	BUY Exercise of conversion of derivative security	$68,888 $8.85 p/Share	7,784 Added 50.0%	7,784 Ordinary Shares
Mar 12 2021	SELL Open market or private sale	$64,264 $29.0 p/Share	2,216 Reduced 100.0%	0 Ordinary Shares
Mar 12 2021	BUY Exercise of conversion of derivative security	$19,634 $8.86 p/Share	2,216 Added 50.0%	2,216 Ordinary Shares

Also insider at

SNDX

Syndax Pharmaceuticals Inc Healthcare

UROV

Urovant Sciences Ltd.

Director

Pierre Legault

Director

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCYC shares.

Notify only if

Value

Insider Trading

Get notified when an Bicycle Therapeutics PLC insider buys or sells BCYC shares.

Notify only if

Operation

Value

Type

News

Receive news related to BICYCLE THERAPEUTICS plc

Track Activities on BCYC

Account